After FDA Fight, MAPS Launches Cannabis PTSD Study for Veterans
The Multidisciplinary Association for Psychedelic Studies (MAPS) has selected Changemark Research + Evaluation as the contract research organization for its long-awaited Phase 2 trial of smoked cannabis for the treatment of PTSD in U.S. veterans. The women-owned and women-led firm will guide site selection and recruitment, with projections pointing to the first participant beginning treatment